VC  Excel Venture Management

http://www.excelvm.com/





     Office Locations:

200 Clarendon Street, 17th fl
Boston, MA 02116
Phone: 617-450-9800
Fax: 617-450-9749

 

Stages:

  • Early
  • Expansion
  • Growth
  • Late


 

Industries:

  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    Excel Venture Management provides capital, experience and resources to help entrepreneurs, investing in healthcare and life science based diagnostics, tools, services, treatments, and IT. Excel also applies life science platforms to broad markets such as energy, chemicals, IT, defense, and agriculture. Excel typically makes an initial investment of $1-5M with an average total investment of $12-15M in early to late stage companies. Excel does not invest in single molecule drugs.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Caleb Winder Managing Director
    Chris Seitz Venture Fellow
    Juan Enriquez Managing Director
    Rick Blume Managing Director
    Steve Gullans PhD Strategic Advisor

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      10/16/2023


      InfoBionic


      MA


      undisclosed


      Series D


     

    Portfolio companies include:


      Activate Networks
        web link


      Aileron Therapeutics
        web link


      Aventura
        web link


      ClearData
        web link


      ClearDATA Networks
        web link


      Gemphire Therapeutics


      IlluminOss Medical


      InfoBionic
        web link


      Lantos Technologies


      Molecular Templates
        web link


      N-of-One
        web link


      PathoGenetix
        web link


      Qstream
        web link


      ShapeUp
        web link


      WellDoc


      Zipongo


     

    Recent News: